A webinar will take place on Thursday, February 25th from 2-3 PM ET. This free webinar will cover newly developed therapies to treat patients with COVID-19, as well as adapting previously developed drugs to COVID-19. Vaccine distribution will also be discussed.
“This session will review the most recent clinical evidence for the agents that have received FDA approval, emergency use authorization (EUA) as well as those in close contention for FDA analysis. In addition, a brief overview of some of the major consensus guidelines for COVID-19 treatment will be reviewed. Lastly, current recommendations for the development, distribution, and prioritization of vaccine administration will be discussed.” Register here.
(Source: AMPC, 2021)